Search

Christopher M Verdier

Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )

Most Active Art Unit
3745
Art Unit(s)
3401, 2851, 3745, 2899
Total Applications
2960
Issued Applications
2317
Pending Applications
150
Abandoned Applications
493

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13812551 [patent_doc_number] => 10183033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-22 [patent_title] => Triptolide prodrugs [patent_app_type] => utility [patent_app_number] => 15/465377 [patent_app_country] => US [patent_app_date] => 2017-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11587 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465377 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/465377
Triptolide prodrugs Mar 20, 2017 Issued
Array ( [id] => 13986283 [patent_doc_number] => 20190062299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS [patent_app_type] => utility [patent_app_number] => 16/087175 [patent_app_country] => US [patent_app_date] => 2017-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087175 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/087175
Processes for the preparation of heteroaryl carboxylic acids Mar 20, 2017 Issued
Array ( [id] => 15163147 [patent_doc_number] => 10487053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine [patent_app_type] => utility [patent_app_number] => 16/073388 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3695 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073388 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073388
Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine Mar 16, 2017 Issued
Array ( [id] => 14518897 [patent_doc_number] => 10336695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-02 [patent_title] => Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt [patent_app_type] => utility [patent_app_number] => 16/073359 [patent_app_country] => US [patent_app_date] => 2017-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7642 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073359 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073359
Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt Mar 16, 2017 Issued
Array ( [id] => 14500969 [patent_doc_number] => 20190194139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => CYCLIC KETO-AMIDE COMPOUNDS AS CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/083189 [patent_app_country] => US [patent_app_date] => 2017-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41247 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083189 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/083189
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof Mar 7, 2017 Issued
Array ( [id] => 12343353 [patent_doc_number] => 09949948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-24 [patent_title] => Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions [patent_app_type] => utility [patent_app_number] => 15/452065 [patent_app_country] => US [patent_app_date] => 2017-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 20506 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452065 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/452065
Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions Mar 6, 2017 Issued
Array ( [id] => 12526875 [patent_doc_number] => 10005801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Compounds for pH-controlled release of hydrogen sulfide [patent_app_type] => utility [patent_app_number] => 15/447797 [patent_app_country] => US [patent_app_date] => 2017-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 8521 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447797 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/447797
Compounds for pH-controlled release of hydrogen sulfide Mar 1, 2017 Issued
Array ( [id] => 13063085 [patent_doc_number] => 10052312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use [patent_app_type] => utility [patent_app_number] => 15/447205 [patent_app_country] => US [patent_app_date] => 2017-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137721 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1074 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447205 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/447205
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use Mar 1, 2017 Issued
Array ( [id] => 16572892 [patent_doc_number] => 10894805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-19 [patent_title] => Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one [patent_app_type] => utility [patent_app_number] => 16/082025 [patent_app_country] => US [patent_app_date] => 2017-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6870 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082025 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/082025
Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one Feb 28, 2017 Issued
Array ( [id] => 15483043 [patent_doc_number] => 10556854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Bacterial efflux pump inhibitors [patent_app_type] => utility [patent_app_number] => 16/078576 [patent_app_country] => US [patent_app_date] => 2017-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15210 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078576 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/078576
Bacterial efflux pump inhibitors Feb 22, 2017 Issued
Array ( [id] => 11668810 [patent_doc_number] => 20170157530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'FURAN-2,5-DICARBOXYLIC ACID PURGE PROCESS' [patent_app_type] => utility [patent_app_number] => 15/435362 [patent_app_country] => US [patent_app_date] => 2017-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6740 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435362 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/435362
Furan-2,5-dicarboxylic acid purge process Feb 16, 2017 Issued
Array ( [id] => 12219116 [patent_doc_number] => 20180057474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => '2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals' [patent_app_type] => utility [patent_app_number] => 15/435075 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17339 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/435075
2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals Feb 15, 2017 Abandoned
Array ( [id] => 12118710 [patent_doc_number] => 20180002296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE' [patent_app_type] => utility [patent_app_number] => 15/435119 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435119 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/435119
S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE Feb 15, 2017 Abandoned
Array ( [id] => 11669964 [patent_doc_number] => 20170158684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'NOVEL COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRAL DISEASES CONTAINING SAME AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 15/433536 [patent_app_country] => US [patent_app_date] => 2017-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27476 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433536 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/433536
Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient Feb 14, 2017 Issued
Array ( [id] => 16184430 [patent_doc_number] => 10717734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-21 [patent_title] => Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof [patent_app_type] => utility [patent_app_number] => 16/076985 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 38657 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 466 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076985
Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof Feb 9, 2017 Issued
Array ( [id] => 16184429 [patent_doc_number] => 10717733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-21 [patent_title] => Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof [patent_app_type] => utility [patent_app_number] => 16/076979 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 42839 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 442 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076979 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076979
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof Feb 9, 2017 Issued
Array ( [id] => 13867293 [patent_doc_number] => 20190029987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => DIMETHYL FUMARATE (DMF) FOR PREVENTION OR TREATMENT OF GOUT, ACNE, DIABETES, VITILIGO AND/OR PYODERMA GANGRENOSUM [patent_app_type] => utility [patent_app_number] => 16/077476 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077476 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/077476
DIMETHYL FUMARATE (DMF) FOR PREVENTION OR TREATMENT OF GOUT, ACNE, DIABETES, VITILIGO AND/OR PYODERMA GANGRENOSUM Feb 9, 2017 Abandoned
Array ( [id] => 11954638 [patent_doc_number] => 20170258789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'DNA-PK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/426150 [patent_app_country] => US [patent_app_date] => 2017-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30066 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426150 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/426150
DNA-PK inhibitors Feb 6, 2017 Issued
Array ( [id] => 13928903 [patent_doc_number] => 20190047967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => BLUE LIGHT CUTTING OPTICAL MATERIAL COMPRISING A BENZOTRIAZOLE UV ABSORBER [patent_app_type] => utility [patent_app_number] => 16/076426 [patent_app_country] => US [patent_app_date] => 2017-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8524 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076426 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076426
Blue light cutting optical material comprising a benzotriazole UV absorber Feb 6, 2017 Issued
Array ( [id] => 15422423 [patent_doc_number] => 10544124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Substituted 2-(het)arylimidazolylcarboxyamides as pesticides [patent_app_type] => utility [patent_app_number] => 16/076786 [patent_app_country] => US [patent_app_date] => 2017-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30910 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 399 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076786 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/076786
Substituted 2-(het)arylimidazolylcarboxyamides as pesticides Feb 5, 2017 Issued
Menu